MTVA vs NBTX

MetaVia Inc. vs Nanobiotix S.A. — Valuation Comparison 2026

MTVA

Biotechnology
MetaVia Inc.
Quality
3.7
out of 10
Value Trap
39
LOW
Price
$3.10
Last close
Models
9/13
Active
VS

NBTX

Biotechnology
Nanobiotix S.A.
Quality
5.0
out of 10
Value Trap
18
SAFE
Price
$40.41
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType MTVA Fair ValueMTVA Upside NBTX Fair ValueNBTX Upside
Bayesian DCF Intrinsic $1.77 -43.0% $9.06 -77.6%
Earnings Power Value Intrinsic $0.83 -42.4%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $3.90 +25.8% $40.14 -0.7%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for MTVA vs NBTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MTVA vs NBTX — Which Stock Is More Undervalued?

NBTX scores higher with a 5.0/10 quality rating vs MTVA's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing MetaVia Inc. (MTVA) and Nanobiotix S.A. (NBTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MTVA currently trades at $3.10 with a QOC of 3.7/10, while NBTX trades at $40.41 with a QOC of 5.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).